These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19363607)

  • 21. Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.
    Son KM; Lee SY; Seo YI; Choi JE; Kim HA
    Clin Rheumatol; 2017 Jun; 36(6):1221-1227. PubMed ID: 28451869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absent "Window of Opportunity" in smokers with short disease duration. Data from BARFOT, a multicenter study of early rheumatoid arthritis.
    Söderlin MK; Bergman S;
    J Rheumatol; 2011 Oct; 38(10):2160-8. PubMed ID: 21807778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effectiveness of methotrexate for the escape by salazosulfapyridine].
    Kawasaki Y; Moriyama M; Shibata K; Gomita Y
    Yakugaku Zasshi; 2005 Jul; 125(7):579-82. PubMed ID: 15997214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine.
    Aono H; Hasunuma T; Fujisawa K; Nakajima T; Yamamoto K; Mita S; Nishioka K
    J Rheumatol; 1996 Jan; 23(1):65-70. PubMed ID: 8838510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Examination of the escape phenomenon in disease modifying antirheumatic drugs].
    Kawasaki Y; Moriyama M; Shibata K; Gomita Y
    Yakugaku Zasshi; 2005 Mar; 125(3):293-7. PubMed ID: 15738628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Soubrier M; Zerkak D; Gossec L; Ayral X; Roux C; Dougados M
    J Rheumatol; 2006 Jul; 33(7):1243-6. PubMed ID: 16622906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate.
    Ogrendik M
    South Med J; 2007 Feb; 100(2):135-9. PubMed ID: 17330681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P; Esselens G; Westhovens R
    Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active Rheumatoid Arthritis in Central Africa: A Comparative Study Between Sudan and Sweden.
    Elshafie AI; Elkhalifa AD; Elbagir S; Aledrissy MI; Elagib EM; Nur MA; Weitoft T; Rönnelid J
    J Rheumatol; 2016 Oct; 43(10):1777-1786. PubMed ID: 27481904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.
    Wechalekar MD; Lester S; Proudman SM; Cleland LG; Whittle SL; Rischmueller M; Hill CL
    Arthritis Rheum; 2012 May; 64(5):1316-22. PubMed ID: 22135142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM).
    Yamanaka H; Tanaka Y; Sekiguchi N; Inoue E; Saito K; Kameda H; Iikuni N; Nawata M; Amano K; Shinozaki M; Takeuchi T
    Mod Rheumatol; 2007; 17(1):28-32. PubMed ID: 17278019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
    Söderlin MK; Petersson IF; Geborek P
    Scand J Rheumatol; 2012 Feb; 41(1):1-9. PubMed ID: 22118371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent trends in use of nonbiologic DMARDs and evaluation of their continuation rates in single and dual combination therapies in rheumatoid arthritis patients in Japan.
    Ogasawara M; Kageyama M; Kusaoi M; Onuma S; Kon T; Sekiya F; Sugimoto K; Matsudaira R; Matsushita M; Tada K; Kempe K; Yamaji K; Tamura N; Takasaki Y
    Mod Rheumatol; 2012 Nov; 22(6):831-6. PubMed ID: 22350576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial.
    Kawai S; Takeuchi T; Yamamoto K; Tanaka Y; Miyasaka N
    Mod Rheumatol; 2011 Oct; 21(5):458-68. PubMed ID: 21347803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].
    Ndongo S; Pouye A; Lekpa FK; Bihéhé DM; Tiendrebeogo J; Ndao AC; Ka MM; Moreira Diop T
    Med Sante Trop; 2012; 22(4):385-9. PubMed ID: 23352953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.